|
Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer
|
journal
|
July 2015 |
|
Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes
|
journal
|
May 2016 |
|
The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics
|
journal
|
July 2017 |
|
Profiling Tumor Infiltrating Immune Cells with CIBERSORT
|
book
|
January 2018 |
|
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study
|
journal
|
December 2022 |
|
T cell activation by clustered tyrosine kinases
|
journal
|
July 1993 |
|
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|
journal
|
January 2017 |
|
CpG island methylator phenotype (CIMP) in cancer: Causes and implications
|
journal
|
September 2008 |
|
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
|
journal
|
March 2021 |
|
Proteogenomic and metabolomic characterization of human glioblastoma
|
journal
|
April 2021 |
|
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
|
journal
|
June 2021 |
|
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
|
journal
|
March 2022 |
|
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes
|
journal
|
August 2022 |
|
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
|
journal
|
January 2023 |
|
Proteogenomic data and resources for pan-cancer analysis
|
journal
|
August 2023 |
|
Hallmarks of Cancer: The Next Generation
|
journal
|
March 2011 |
|
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
|
journal
|
January 2015 |
|
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
|
journal
|
September 2015 |
|
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
|
journal
|
July 2016 |
|
A Landscape of Pharmacogenomic Interactions in Cancer
|
journal
|
July 2016 |
|
AKT/PKB Signaling: Navigating the Network
|
journal
|
April 2017 |
|
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
|
journal
|
November 2017 |
|
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
|
journal
|
May 2019 |
|
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
|
journal
|
October 2019 |
|
Proteogenomic Characterization of Endometrial Carcinoma
|
journal
|
February 2020 |
|
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
|
journal
|
July 2020 |
|
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
|
journal
|
November 2020 |
|
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
|
journal
|
December 2020 |
|
A proteogenomic portrait of lung squamous cell carcinoma
|
journal
|
August 2021 |
|
Proteogenomic characterization of pancreatic ductal adenocarcinoma
|
journal
|
September 2021 |
|
Glioblastoma hijacks neuronal mechanisms for brain invasion
|
journal
|
August 2022 |
|
Pan-cancer proteogenomics connects oncogenic drivers to functional states
|
journal
|
August 2023 |
|
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
|
journal
|
October 2020 |
|
The Molecular Signatures Database Hallmark Gene Set Collection
|
journal
|
December 2015 |
|
The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis
|
journal
|
June 2023 |
|
The Immune Landscape of Cancer
|
journal
|
April 2018 |
|
Germline genetic contribution to the immune landscape of cancer
|
journal
|
February 2021 |
|
Derivation of CD8+ T cell infiltration potentiators in non-small-cell lung cancer through tumor microenvironment analysis
|
journal
|
July 2023 |
|
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell Lung Cancer
|
journal
|
June 2019 |
|
Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma Risk
|
journal
|
December 2020 |
|
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
|
journal
|
February 2018 |
|
Akt in cancer: Mediator and more
|
journal
|
December 2019 |
|
Predicting endometrial cancer subtypes and molecular features from histopathology images using multi-resolution deep learning models
|
journal
|
September 2021 |
|
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
|
journal
|
September 2023 |
|
Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues
|
journal
|
July 2016 |
|
Signatures of mutational processes in human cancer
|
journal
|
August 2013 |
|
Proteogenomic characterization of human colon and rectal cancer
|
journal
|
July 2014 |
|
PD-1 blockade induces responses by inhibiting adaptive immune resistance
|
journal
|
November 2014 |
|
Proteogenomics connects somatic mutations to signalling in breast cancer
|
journal
|
May 2016 |
|
Inferring tumour purity and stromal and immune cell admixture from expression data
|
journal
|
October 2013 |
|
MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry–based proteomics
|
journal
|
April 2017 |
|
Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses
|
journal
|
February 2012 |
|
Roles and mechanisms of BAP1 deubiquitinase in tumor suppression
|
journal
|
January 2021 |
|
Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors
|
journal
|
April 2020 |
|
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
|
journal
|
September 2021 |
|
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
|
journal
|
February 2022 |
|
Interpretable and context-free deconvolution of multi-scale whole transcriptomic data with UniCell deconvolve
|
journal
|
March 2023 |
|
Systemic immunity in cancer
|
journal
|
April 2021 |
|
The repertoire of mutational signatures in human cancer
|
journal
|
February 2020 |
|
An atlas of substrate specificities for the human serine/threonine kinome
|
journal
|
January 2023 |
|
Targeting TBK1 to overcome resistance to cancer immunotherapy
|
journal
|
January 2023 |
|
Cellpose: a generalist algorithm for cellular segmentation
|
journal
|
December 2020 |
|
Philosopher: a versatile toolkit for shotgun proteomics data analysis
|
journal
|
July 2020 |
|
DNA methylation signature of smoking in lung cancer is enriched for exposure signatures in newborn and adult blood
|
journal
|
March 2019 |
|
Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
|
journal
|
January 2023 |
|
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|
journal
|
September 2005 |
|
Diagnosis of multiple cancer types by shrunken centroids of gene expression
|
journal
|
May 2002 |
|
Cauchy Combination Test: A Powerful Test With Analytic p-Value Calculation Under Arbitrary Dependency Structures
|
journal
|
April 2019 |
|
Large-Scale Hypothesis Testing for Causal Mediation Effects with Applications in Genome-wide Epigenetic Studies
|
journal
|
May 2021 |
|
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
|
journal
|
May 2012 |
|
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
|
journal
|
February 2010 |
|
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
|
journal
|
April 2010 |
|
Molecular signatures database (MSigDB) 3.0
|
journal
|
May 2011 |
|
Matrix eQTL: ultra fast eQTL analysis via large matrix operations
|
journal
|
April 2012 |
|
CancerSubtypes: an R/Bioconductor package for molecular cancer subtype identification, validation and visualization
|
journal
|
June 2017 |
|
A new method for constructing tumor specific gene co-expression networks based on samples with tumor purity heterogeneity
|
journal
|
June 2018 |
|
Adjusting batch effects in microarray expression data using empirical Bayes methods
|
journal
|
April 2006 |
|
A map of tumor–host interactions in glioma at single-cell resolution
|
journal
|
October 2020 |
|
KEGG: Kyoto Encyclopedia of Genes and Genomes
|
journal
|
January 2000 |
|
The Dark Kinase Knowledgebase: an online compendium of knowledge and experimental results of understudied kinases
|
journal
|
October 2020 |
|
KEA3: improved kinase enrichment analysis via data integration
|
journal
|
May 2021 |
|
GENCODE: reference annotation for the human and mouse genomes in 2023
|
journal
|
November 2022 |
|
SigCom LINCS: data and metadata search engine for a million gene expression signatures
|
journal
|
May 2022 |
|
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
|
journal
|
May 2016 |
|
ChEA3: transcription factor enrichment analysis by orthogonal omics integration
|
journal
|
May 2019 |
|
Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses
|
journal
|
January 2020 |
|
Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
|
journal
|
September 2017 |
|
Tmic-62. fyn, an Effector of Oncogenic Receptor Tyrosine Kinases Signaling in Glioblastoma, Inhibits Anti-Glioma Immune Responses: Implications for Immunotherapy
|
journal
|
November 2019 |
|
Increased Prevalence of Strongly Positive Tuberculin skin Reactions in Children from a Desert Agricultural Community in Israel
|
journal
|
August 1987 |
|
Repressive role of stabilized hypoxia inducible factor 1α expression on transforming growth factor β‐induced extracellular matrix production in lung cancer cells
|
journal
|
May 2019 |
|
Impact of molecular and clinical variables on survival outcome with immunotherapy for glioblastoma patients: A systematic review and meta‐analysis
|
journal
|
July 2022 |
|
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
|
journal
|
January 1995 |
|
Mutational signatures associated with tobacco smoking in human cancer
|
journal
|
November 2016 |
|
Pan-cancer single-cell landscape of tumor-infiltrating T cells
|
journal
|
December 2021 |
|
Smoking Methylation Marks for Prediction of Urothelial Cancer Risk
|
journal
|
December 2021 |
|
Rare, Pathogenic Germline Variants in Fanconi Anemia Genes Increase Risk for Squamous Lung Cancer
|
journal
|
March 2019 |
|
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
|
journal
|
March 2023 |
|
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
|
journal
|
July 2018 |
|
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors
|
journal
|
January 2021 |
|
Epigenetic Signatures of Cigarette Smoking
|
journal
|
October 2016 |
|
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
|
journal
|
January 2013 |
|
GSVA: gene set variation analysis for microarray and RNA-Seq data
|
journal
|
January 2013 |
|
The characteristic direction: a geometrical approach to identify differentially expressed genes
|
journal
|
January 2014 |
|
Tyrosine Phosphorylation in Immune Cells: Direct and Indirect Effects on Toll-Like Receptor-Induced Proinflammatory Cytokine Production
|
journal
|
January 2009 |
|
Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer
|
journal
|
June 2022 |
|
Are polygenic risk scores ready for the cancer clinic?—a perspective
|
journal
|
May 2022 |
|
CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma
|
journal
|
December 2021 |
|
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
|
journal
|
November 2021 |
|
Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma
|
journal
|
December 2020 |
|
The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
|
journal
|
December 2020 |
|
Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies
|
journal
|
January 2020 |
|
Regulation of Immune Cell Function by PPARs and the Connection with Metabolic and Neurodegenerative Diseases
|
journal
|
May 2018 |
|
Peroxisome Proliferator-Activated Receptor-γ Activators Inhibit IFN-γ-Induced Expression of the T Cell-Active CXC Chemokines IP-10, Mig, and I-TAC in Human Endothelial Cells
|
journal
|
June 2000 |
|
Kindlin-1 regulates IL-6 secretion and modulates the immune environment in breast cancer models
|
journal
|
March 2023 |